PHOENIX, Nov. 13, 2015 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Creative Edge Nutrition (OTCMKTS:FITX), EKSO BIONICS (OTCBB:EKSO), Cellceutix (OTCMKTS:CTIX), Angie's List (NASDAQ: ANGI), MannKind (NASDAQ: MNKD), and Sirius XM (NASDAQ: SIRI).
(Read full report by clicking the links below, you may need to copy and paste the full link to your browser.)
Creative Edge Nutrition Inc (OTCMKTS:FITX): By the end of last trading, the Creative Edge Nutrition (OTCMKTS:FITX) shares soared 24.44% (or US$0.00110) to US$0.00560 with about 64.00 million shares changing hands for the session, compared to its average volume of 6.50 million shares. Since Health Canada didn't give the company a license to grow marijuana, the ticker fell back into near-illiquid obscurity which it barely leaves nowadays. The company's ex-CEO Bahige "Bill" Chaaban had already sold US$5 million worth of his own stock. The Company is headed up by new CEO James Robinson who has a vision to launch an industry leading energy drink line, including two primary business subsidiaries: CEN-BIOTECH and CENERGY NUTRITION. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report Mere.
EKSO BIONICS HOLDING (OTCBB:EKSO): By the end of last trading, the EKSO BIONICS (OTCBB:EKSO) shares lost 9.23% (or US$0.12) to US$1.18 with about 0.845 million shares changing hands for the session, compared to its average volume of 0.280 million shares. The company published its quarterly report on Monday, the Q3 revenues have grown even on a QoQ basis, by a fair 38%. There is virtually no dilution, with around 250 thousand new shares issued since the company last reported on its outstanding shares figure. Is there any insider trading in this company? Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/111315A/EKSO/EKSOBIONICS.pdf
Cellceutix Corp (OTCMKTS:CTIX): By the end of last trading, the Cellceutix (OTCMKTS:CTIX) shares declined 8.54% (or US$0.14) to US$1.50 with about 0.392 million shares changing hands for the session, compared to its average volume of 0.302 million shares. According to its latest fiscal report, the company's lack of revenues since its drugs are still in development stage. But the company has sizable cash reserves with another $28.2 million available through stock sales under the terms of the purchase agreement with Aspire Capital. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/111315A/CTIX/Cellceutix.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Angie's List Inc (NASDAQ: ANGI):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/111315A/ANGI/AngiesList.pdf
MannKind Corporation (NASDAQ: MNKD):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/111315A/MNKD/MannKind.pdf
Sirius XM Holdings Inc. (NASDAQ: SIRI):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/111315A/SIRI/SiriusXM.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.